Table 1 Demographic and clinical characteristics
From: Recovery of new-onset kidney disease in COVID-19 patients discharged from hospital
Clinical characteristics | No. | Summary |
|---|---|---|
Age, years | 143 | 64 (51, 70) |
Male patients, No (%) | 143 | 85 (59.4) |
Fever on admission, No (%) | 143 | 46 (32.2) |
Systolic blood pressure, mmHg | 143 | 128 (115, 141) |
Diastolic blood pressure, mmHg | 143 | 80 (71, 88) |
Smoking, No (%) | 143 | 9 (6.3) |
Any comorbidity, No (%) | 143 | 69 (48.3) |
Chronic lung disease, No (%) | 143 | 10 (7.0) |
Diabetes, No (%) | 143 | 26 (18.2) |
Hypertension, No (%) | 143 | 48 (33.6) |
Tumor, No (%) | 143 | 7 (4.9) |
Blood urea nitrogen, mg/dL | 143 | 4.9 (3.9, 6.3) |
Admission SCr, mg/dL | 143 | 77 (61, 93) |
Peak SCr, mg/dL | 143 | 84 (67, 99) |
Discharge SCr, mg/dL | 106 | 68 (60, 84) |
Admission eGFR, ml/min/1.73 m2 | 143 | 88 (71, 100) |
Peak eGFR, ml/min/1.73 m2 | 143 | 81 (65, 93) |
Discharge eGFR, ml/min/1.73 m2 | 106 | 93 (82, 103) |
Admission proteinuria | 120 | 117 (97.5) |
1+ | 120 | 99 (82.5) |
2 + ~ 3+ | 120 | 18 (15.0) |
Peak proteinuria | 136 | 130 (95.5) |
1+ | 136 | 107 (78.6) |
2 + ~ 3+ | 136 | 23 (16.9) |
discharge proteinuria | 40 | 10 (25.0) |
1+ | 40 | 9 (22.5) |
2 + ~ 3+ | 40 | 1 (2.5) |
Leukocyte count, × 109/L | 143 | 6.2 (4.6, 8.7) |
Lymphocyte count, × 109/L | 143 | 0.8 (0.6, 1.0) |
Platelet count, × 109/L | 143 | 197 (149, 269) |
Hemoglobin, g/L | 143 | 129 (121, 139) |
D-dimer, mg/L | 135 | 39 (19, 97) |
hs-CRP, mg/L | 134 | 84 (34, 134) |
Admission to intensive care unit, No (%) | 143 | 7 (0.05) |
Mechanical ventilation, No (%) | 143 | 24 (16.8) |
Non-invasive, No (%) | 143 | 22 (15.4) |
Invasive, No (%) | 143 | 6 (4.2) |
ECMO, No (%) | 143 | 3 (2.1) |
Hospital length of stay, days | 143 | 27 (21, 35) |